1 completed, 1 recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Craving: new trials by email Literature Review of Craving trials Research Report on Craving
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving Cannabidiol (CBD), Placebo - Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification | Phase 2 / Phase 3 | Recruiting | Johns Hopkins University | 105 | 2026-10-21 | 2026-11-03 |
| The Efficacy of Suvorexant in Treatment of Patients With Substance Use Disorder and Insomnia: A Pilot Open Trial Suvorexant 20 mg - Sleep Disturbance, Craving | Phase 2 / Phase 3 | Completed | Milton S. Hershey Medical Center | 28 | 2019-07-01 | 2024-02-13 |
Alcohol Abstinence (1) · Alcoholism (1) · Parasomnias (1)
Mental Disorders (2) · Alcohol-Related Disorders (1) · Behavior (1) · Chemically-Induced Disorders (1) · Drinking Behavior (1) · Nervous System Diseases (1) · Sleep Wake Disorders (1) · Substance-Related Disorders (1)
Cannabidiol (1) · suvorexant (1)
Johns Hopkins University (1) · Milton S. Hershey Medical Center (1)
United States (2)
David Woliinsky, MD (1) · Venkatesh Basappa Krishnamurthy, MD (1)